Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Higher inflammation markers are linked to more severe alopecia areata.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Long COVID symptoms vary and are influenced by personal and health factors.

The document concludes that objective methods are important for diagnosing different types of alopecia and monitoring treatment, and standardizing these techniques is necessary.

Age, gender, obesity, and smoking increase the risk of severe COVID-19.

Red and near-infrared light-emitting fabric may help improve psoriasis, PMLE, and alopecia areata.

CAR is a useful marker for assessing alopecia areata severity.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.

Patients with alopecia areata and eosinophilia have more nail issues and severe hair loss.

Addressing psychosocial symptoms can improve outcomes for people with Hidradenitis Suppurativa.

Higher androgen levels are linked to more severe hair growth in hirsute women.

Parental socioeconomic status doesn't improve dietary habits or reduce disease severity in children with sickle cell disease.

Higher EGF levels are linked to more severe alopecia areata.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Lower BDNF levels link to worse depression in alopecia areata patients.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

More severe alopecia areata can lower quality of life.

There is a need for better treatments for severe alopecia areata.

Severe COVID-19 often leads to hair loss in India.

Most adverse reactions to the treatment were mild, with nausea being the most common.

Trichoscopy is a useful tool for diagnosing and assessing the severity of alopecia areata.

Severe hair loss may increase the risk of dying from COVID-19.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

The document's conclusion cannot be provided because the content is not available.